B.P. Koirala Institute of Health Sciences   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Dharan Nepal (1993)

Organization Overview

First Clinical Trial
2009
NCT01856205
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

BPKIHS | B. P. K. I. H. S. | BPKIHS, Dharan | BP Koirala Institute of health sciences | B.P. Koirala Institute of Health Sciences | BP Koirala Institute of Health Sciences | B.P. Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal | Rajesh Deshar

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Agnosia (Phase 4)

Cholecystolithiasis (Phase 4)

Cholelithiasis (Phase 4)

Chronic Pain (Phase 4)

Cough (Phase 4)

Dwarfism (Phase 4)

Dysphonia (Phase 4)

Encephalitis (Phase 2)

Encephalitis, Japanese (Phase 2)

Gallstones (Phase 4)

Herpes Zoster (Phase 4)

Hoarseness (Phase 4)

Hypotension (Phase 4)

Lichen Planus (Phase 4)

Lichen Planus, Oral (Phase 4)

Neuralgia (Phase 4)

Pain, Postoperative (Phase 4)

Pharyngitis (Phase 4)

Snake Bites (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 43